Sempre Health Raises $15M in Series B Financing

Sempre Health

Sempre Health, a San Francisco, CA-based provider of a behavior-based healthcare pricing solution, closed a $15M Series B financing.

The round was led by the Blue Venture Fund – a collaboration among Blue Cross Blue Shield (BCBS) companies, the Blue Cross Blue Shield Association, and Sandbox, with participation from UPMC Enterprises and existing investors Rethink Impact, LifeForce Capital and Industry Ventures.

The company intends to use the funds to advance its two-sided network of payors and pharma manufacturers nationwide and further grow the number of chronic disease patients Sempre can help access their medications.

Led by Anurati Mathur, CEO, Sempre Health works with health plans and pharmaceutical companies to reduce costs for patients who refill their prescriptions on time. By combining technology, behavioral science, and dynamic pricing, Sempre Health aims to boost all of its members’ medication adherence to exceed 80 percent of days covered, improve the health of people and save hundreds of billions of dollars in avoidable medical costs. 

FinSMEs

16/06/2021